Quality at good valuations beats hunting under-the-radar names

Conviction: 70% · Horizon: 5Y · 2026-07-28
Widely followed quality names can still compound if fundamentals and valuation remain attractive

Investor attention is skewed toward undiscovered micro-ideas, while solid companies already on shared watchlists can keep delivering multi-year returns when growth and valuation are intact. Buying quality at reasonable prices and holding reduces the need to constantly rotate into the next obscure story.

Instrument Side Target Reason
LMND Long Insurance platform with a multi-year AI edge that can scale underwriting and operations, supporting a decade-scale growth thesis rather than a short-cycle trade.
CRDO Long Connectivity silicon with optics exposure that is still underappreciated relative to the structural rise in data-center bandwidth demand.
ZETA Long Marketing and data platform expected to grow EBITDA at a high-teens to low-twenties CAGR while still trading at a modest multiple of forward EBITDA, combining growth with valuation support.
OUST Long Perception and sensing pure-play tied to robotics and automation, with rapid top-line growth as machines need better environmental awareness.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.